Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors
- First Posted Date
- 2009-06-22
- Last Posted Date
- 2010-05-04
- Lead Sponsor
- Cellectar, Inc
- Target Recruit Count
- 9
- Registration Number
- NCT00925275
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸Georgetown University, Lombardi Cancer Center, Washington, District of Columbia, United States
🇺🇸Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
News
No news found